Characteristics of antibiotic sensitivity of Acinetobacter baumannii bv. tryptophandestruens and Acinetobacter baumannii clinical isolates
- Authors: Sivolodskii E.P.1,2, Kraeva L.A.1,2, Melnikova E.V.1, Gorelova G.V.1
-
Affiliations:
- Military Medical Academy named after S.M. Kirov
- St. Petersburg Pasteur Institute
- Issue: Vol 14, No 1 (2024)
- Pages: 170-174
- Section: SHORT COMMUNICATIONS
- URL: https://journal-vniispk.ru/2220-7619/article/view/256778
- DOI: https://doi.org/10.15789/2220-7619-COA-17521
- ID: 256778
Cite item
Full Text
Abstract
The aim of the study was to determine the sensitivity of the bacteria of the biovar Acinetobacter baumannii bv. tryptophandestruens to antibiotics used to treat Acinetobacter-infection. The object of the study was 86 primary clinical isolates of A. baumannii, of which 34 strains of A. baumannii bv. tryptophandestruens isolated in the microbiological laboratory of the Military Medical Academy in 2021–2022. Species identification of bacteria was carried out by MALDI-ToF mass spectrometry. The biovar tryptophandestruens of A. baumannii was determined on a dense chromogenic medium. The sensitivity of A. baumannii isolates to antibiotics was determined by a “Vitek 2 compact” microbiological analyzer (bioMerieux, France). Clinical categories of isolates sensitivity to antibiotics (S) were identified based on the boundary values of minimum suppressive concentrations (MSC, mg/L) established by the European Committee for the Determination of Sensitivity to Antimicrobial Preparates (EUCAST), version 11.0. Isolates of A. baumannii bv. tryptophandestruens and groups of isolates of other A. baumannii very rarely sensitive to meropenem (8.8±4.6%; 3.8±2.6%, respectively, p > 0.05), ciprofloxacin (5.8±4.0; 9.6±4.1%, p > 0.05). Strains sensitive to gentamicin are rarely represented in both groups (26.7±7.55; 19.3±5.5%, p > 0.05) trimethoprim/sulfamethoxazole (38.8±8.3%; 23.6±5.3%, p > 0.05). Sensitivity to polymyxin B was preserved in all strains of both groups (100%). Strains of the tryptophandestruens biovar A. baumannii group surpass strains of the other strain of A. baumannii group in the frequency of isolates with MSC50% tigecycline (MSC50% — 0.5 mg/l; MSC50% — 2 mg/l, respectively), and also have significantly more strains with MSC 0.5 mg/l (52.9% and 15.4%, respectively, p < 0.01 ). Thus, the clinical isolates of the biovar A. baumannii bv. tryptophandestruens have no significant differences with isolates of other strains of A. baumannii in the frequency of strains sensitive (S) to meropenem, ciprofloxacin, gentamicin, trimethoprim/sulfamethoxazole, polymyxin B, but they differ in terms of sensitivity to tigecycline — a higher frequency of strains with an MSC of 0.5 mg/l (p < 0.01) and an MSC of 50%.
Full Text
##article.viewOnOriginalSite##About the authors
E. P. Sivolodskii
Military Medical Academy named after S.M. Kirov; St. Petersburg Pasteur Institute
Email: lykraeva@yandex.ru
DSc (Medicine), Professor of the Department of Microbiology, Senior Researcher, Laboratory of Molecular and Biological Technologies
Russian Federation, St. Peterburg; St. PeterburgL. A. Kraeva
Military Medical Academy named after S.M. Kirov; St. Petersburg Pasteur Institute
Author for correspondence.
Email: lykraeva@yandex.ru
DSc (Medicine), Head of the Laboratory of Medical Bacteriology, Professor of the Department of Microbiology
Russian Federation, St. Petersburg; St. PetersburgE. V. Melnikova
Military Medical Academy named after S.M. Kirov
Email: lykraeva@yandex.ru
Bacteriologist, Laboratory of Bacteriology of the Central Clinical Diagnostic Laboratory
Russian Federation, St. PeterburgG. V. Gorelova
Military Medical Academy named after S.M. Kirov
Email: lykraeva@yandex.ru
Head of the Laboratory of Bacteriology, Central Clinical Diagnostic Laboratory
Russian Federation, St. PeterburgReferences
- Клинические рекомендации. Определение чувствительности микроорганизмов к антимикробным препаратам. Версия 2021-01. Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии. [Clinical guidelines. Susceptibility testing to antimicrobial agents.v. 2021-01. Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC). (In Russ.)] URL: https://www.antibiotic.ru/files/321/clrec-dsma2021.pdf
- Патент № 2787267 Российская Федерация. МПК G01N 33/48(2006.01), C12Q1/04(2006.01), СПК G01 33/48(2022.08), C12Q1/04(2022.080, C12Q1/045(2022.08), C12Q2304/00(2022.08). Способ идентификации биовара бактерий Acinetobacter baumannii bv. tryptophandestruens; № 2022109368, заявлено 2022.04.07, опубликовано 2023.01.09 / Сиволодский Е.П. Патентообладатель Сиволодский Евгений Петрович.7 с. [Patent No 2787267 Russian Federation, Int.Cl. G01 33/48(2006.01), C12Q1/04(2006.01), SP.CL.G01N 33/48(2022.08), C12Q1/04(2022.08), C12Q1/04592022.08), C12Q 2304/00(2022.08). Metod of identificccation of biovar bacteria Acinetobacter baumannii bv. tryptophandestruens; No 2023109368, application 2022.04.07.; date of publication 2023.01.09 / Sivolodskij T.P. Proprittors. Sivolodskij Evgenij Petrovich.7 p. (In Russ.)].
- Сиволодский Е.П., Краева Л.А., Старкова Д.А., Михайлоов Н.В., Горелова Г.А. Acinetobacter baumannii bv. tryptophandestruens bv. nov., выделенный из клинического материала // Инфекция и иммунитет. 2021. Т. 11, № 5. С. 965–972. [Sivolodskii E.P., Kraeva L.A., Starkova D.A., Mikhailov N.V., Gorelova G.V. Acinetobacter baumannii bv. tryptophandestruens bv. nov., isolated from clinical samples. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2021, vol. 11, no. 5, pp. 965–972. (In Russ.)] doi: 10.15789/2220-7619-ABB-1676
Supplementary files
